PaperPanda Equity Terminal

VRTX logo VRTX — VERTEX PHARMACEUTICALS

CUSIP: 92532F100 · Held by 5 superinvestors · Combined value: $624,471,662

Latest News

Loading financials…

Quarterly Activity Chart Adds vs. Reduces by Quarter
Green bars = share additions · Red bars = share reductions
Superinvestor Holders
# Investor % of Portfolio Value ($) Shares Recent Activity Share Change
1 Ken Griffin 0.1% $358,136,266 789,960 ADD +205,058
2 Jim Simons 0.4% $228,968,561 505,048 REDUCE -230,840
3 Tweedy Browne 1.4% $18,034,411 40,387 ADD +1,239
4 Ray Dalio 0.1% $12,461,960 27,488 REDUCE -10,836
5 Torray LLC 1.0% $6,870,464 15,386 REDUCE -80
Quarterly Activity History (3 quarters)
Investor Activity Share Change % Change
Tweedy Browne ADD +1,239 +3.2%
Torray LLC REDUCE -80 -0.5%
Investor Activity Share Change % Change
Ken Griffin ADD +205,058 +35.1%
Tweedy Browne ADD +83 +0.2%
Jim Simons REDUCE -230,840 -31.4%
Ray Dalio REDUCE -10,836 -28.3%
Torray LLC REDUCE -789 -4.9%
Investor Activity Share Change % Change
Ken Griffin ADD +112,175 +23.7%
Ray Dalio ADD +3,934 +11.4%
Jim Simons REDUCE -269,000 -26.8%

Who Owns VRTX? Superinvestor Holdings

VERTEX PHARMACEUTICALS is held by 5 tracked superinvestors, with a combined position value of $624 million . The largest positions are held by Ken Griffin (0.1% of portfolio), Jim Simons (0.4% of portfolio), Tweedy Browne (1.4% of portfolio).

In the most recent quarter, 2 superinvestors added or initiated positions while 3 reduced or exited.